Prehospital Crystalloid Resuscitation: Practice Variation and Associations With Clinical Outcomes

Abstract

Introduction: Although resuscitation guidelines for injured patients favor blood products, crystalloid resuscitation remains a mainstay in prehospital care. Our understanding of contemporary prehospital crystalloid (PHC) practices and their relationship with clinical outcomes is limited. Methods: The Pragmatic, Randomized Optimal Platelet and Plasma Ratios trial data set was used for this investigation. We sought to identify factors associated with PHC volume variation and hypothesized that higher PHC volume is associated with worse coagulopathy and a higher risk of acute respiratory distress syndrome (ARDS) but a lower risk of acute kidney injury (AKI). Subjects were divided into groups that received <1,000 mL PHC (PHC<1,000) and ≥1,000 mL PHC (PHC≥1,000); initial laboratory values and outcomes (ARDS and AKI risk) were summarized with medians and interquartile ranges or percentages and compared using Wilcoxon rank-sum tests and chi-square tests. The primary outcome was ARDS risk. Multivariable regression was used to characterize the association of each 500 mL aliquot of PHC with initial laboratory values and clinical outcomes. Results: PHC volume among study subjects (n = 680) varied (median, 0.3 L; interquartile range, 0–0.9 L) with weak associations demonstrated among prehospital hemodynamics, intubation, Glasgow Coma Score, and Injury Severity Score (0.008 ≤ R2 ≤ 0.09); prehospital time and enrollment site explained more variation in PHC volume with R2 values of 0.2 and 0.54, respectively. Compared with PHC<1,000, PHC≥1,000 had higher INR, PT, PTT, and base deficit and lower hematocrit and platelets. The proportion of ARDS in the PHC≥1,000 group was higher than PHC<1,000 (21% vs. 12%, P < 0.01), whereas the rate of AKI was similar between groups (23% vs. 23%, P = 0.9). In regression analyses, each 500 mL of PHC was associated with increased INR and PTT, and decreased hematocrit and platelet count (P < 0.05). Each 500 mL of PHC was associated with increased ARDS risk and decreased AKI risk (P < 0.05). Conclusion: PHC administration correlates poorly with prehospital hemodynamics and injury characteristics. Increased PHC volume is associated with greater anemia, coagulopathy, and increased risk of ARDS, although it may be protective against AKI.

Acetate Ringer's Solution Versus Normal Saline Solution in Sepsis: A Randomized, Controlled Trial

“…RAS failed to show a benefit in improving the outcome of renal function and mortality for critically ill patients, as also shown by other clinical trials (6,16,22–24). For patients with sepsis/septic shock, early fluid management (in the first 1 to 6 h) plays an essential role.…”

Damage control resuscitation in adult trauma patients: What you need to know

“…Compounding this, large-volume crystalloid administration has been found to worsen systemic acidosis and create an ongoing dilutional coagulopathy further increasing critical organ damage 17,18 . Both prehospital and hospital use of crystalloid, and not blood products, are associated with multiple inflammatory complications, including ARDS 19,20 . These findings, along with the propensity to induce hypothermia secondary to the rapid administration of nonwarmed fluids, represent an iatrogenic resuscitation injury and the accelerates the “lethal triad of death” (i.e., coagulopathy, acidosis, and hypothermia).…”

Coagulopathy Parameters Predictive of Outcomes in Sepsis-induced Acute Respiratory Distress Syndrome: A Sub-Analysis of the Two Prospective Multicenter Cohort Studies

“…Coagulopathy is often observed in patients with sepsis and ARDS and is an important component of MODS (20,21). Up to 20% to 30% of patients with severe sepsis and septic shock have been reported to develop coagulopathy based on several nationwide registries (13,22,23).…”